{
  "docId": "019de070-3657-744f-8469-a4294fbedcbe",
  "docSlug": "17e3f38e05c3dcb59be9aebb9723e39c",
  "documentTitle": "Relay Therapeutics | IPO Presentation Deck | 25 slides",
  "authorId": "relay-therapeutics",
  "authorName": "Relay Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 25,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-3657-744f-8469-a4294fbedcbe/18",
  "deckHref": "/decks/019de070-3657-744f-8469-a4294fbedcbe",
  "deckJsonHref": "/decks/019de070-3657-744f-8469-a4294fbedcbe.json",
  "deckAnchorHref": "/decks/019de070-3657-744f-8469-a4294fbedcbe#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.38,
        "x": 0.03,
        "y": 0.2
      },
      "kind": "diagram",
      "text": "Timeline 2020 Dose Escalation: Advanced solid tumors First Patient In (FPI) Expect clinical update for RLY-1971 in 2021",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e27ad1d5-692f-4800-84ec-de6fca75d843",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.15,
        "x": 0.82,
        "y": 0.03
      },
      "kind": "image",
      "text": "RELAY THERAPEUTICS",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d76bf5ed-680b-48cc-8841-3fd9170de271",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.55,
        "x": 0.42,
        "y": 0.28
      },
      "kind": "list",
      "text": "KRAS G12C Combination: Potential to combat RAS pathway reactivation; Opportunity in Non-Small Cell Lung Cancer and Colorectal Cancer",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc6c0503-5209-4630-993f-d6eb8d8009a0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.55,
        "x": 0.42,
        "y": 0.5
      },
      "kind": "list",
      "text": "Other Potential Combination Opportunities: PI3K, FGFR, ALK, EGFR, MET, MEK, Others",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e3b4f238-d5d7-4184-9856-2945b0e1e7aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "SHP2 – Clinical Plan and Combination Potential",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1f627026-6ba2-4e0c-a20c-4c1fba4ae296",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}